Market Updates

MucoVax Raises Needed Capital

Dutch biotech company MucoVax, Leiden, The Netherlands, recently closed a €3.1 million financing round. This funding will enable the company to accelerate its nutraceutical product development for a range of bioactive milk ingredients with specific functionalities suited for the prevention and treatment of disease.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters